a:head bio AG Accelerates Growth Through Commercial and Scientific Momentum

a:head bio AG today announced the successful completion of a seven-figure financing round, providing additional capital to accelerate the expansion of its human brain organoid platform, advance next-generation disease models, and support growing commercial activities with pharmaceutical and biotechnology partners.